Biomarker profiling in heart rhythm disorder patients
Part of Heart & circulation clinical trials.
This study looks for biomarkers (biological markers in your blood) in people having a heart procedure called catheter ablation for certain heart rhythm problems. The goal is to better understand these conditions and possibly improve future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled to have a catheter ablation for ventricular tachycardia, premature ventricular contractions, or AVNRT.
- You are willing to provide a written consent to participate.
- You do not have an active infection or inflammatory disease at the time of sampling.
- You are not pregnant.
- You are able to comply with study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who are in the hospital for any type of irregular heartbeat (arrhythmia). It aims to learn more about these conditions and may help improve future care.
This study looks at how heart rhythm problems affect heart function. It may help doctors better understand and treat these conditions.
This trial tests a special catheter to map abnormal heart rhythms like ventricular tachycardia or atrial fibrillation. It may help patients who need a procedure to find and treat the source of these fast or irregular heartbeats.
This study looks at the risk of a fast heart rhythm (ventricular tachycardia) in people with genetic heart muscle diseases. It tests whether having a specific genetic change affects the success of a heart ablation procedure.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This study looks at how well catheter ablation works for treating certain heart rhythm disorders (like atrial fibrillation or ventricular arrhythmias) using a specific brand of catheters. The aim is to gather real-world data to better understand the procedure's outcomes.
Hear when a new Arrhythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.